Right heart failure blue book article Flashcards

1
Q

+Which is the most anterior chamber of the heart?

A

RV- lies immediately behind the sternum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

+How does the RV structure facilitate it’s function?

A

Thin-walled, low-pressure, maintains pulmonary perfusion pressure & delivers deoxygenated mixed venous blood to pulmonary vasculature for gas exchange, also maintains low systemic venous pressure which prevents organ congestion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

+What shape is the RV in transverse cross-section

A

crescent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

+What’s mean systemic filling pressure (equation)?

A

MSFP = RAP/(resistance to venous return)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

+What’s normal MSFP & RAP & CVP?

A

MSFP 7-10mmHg
RAP and CVP 0mmHg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

+What is the RV blood supply? what does R) dominant circulation mean?

A

R) CA & it’s branches
in 80% of population the coronary circulation is R) dominant where the R) CA also supplies the inferior wall of the LV & posterior third of the IV septum via the PDA branch. in the other 20%, the PDA arises from the L) CA. So, in 20% of the population, LV perfusion is completely independent of the R) CA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

+How does perfusion of the RV compare with the LV? and the stroke work & O2 demand of the RV?

A

RV perfusion occurs throughout both diastole & systole due to the lower R) heart chamber pressures. In contrast, LV perfusion occurs primarily in diastole due to higher LV systole & contraction pressures. Due to these lower pressures, the RV has only 25% of the stroke work & lower O2 demand than the LV, despite ejecting the same CO.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

+How does the Starling curve of the RV compare to the L)?

A

It’s flatter, consequently there’s lower variation in RV contractility over a wide range of filling pressures. The RV can tolerate a wider & higher range of preload conditions before it fails.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

+What are the pathophysiological mechanisms by which RV dysfunction may occur? How may a more compliant RV cope under these conditions?

A

Pressure overload (increased afterload), volume overload (increased preload), impaired contractility.
Due to it’s structural characteristics & low muscle mass, a more compliant RV can tolerate increases in preload but is less able to tolerate sudden increases in afterload.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

+What are some examples of causes of acute RV failure?

A

Increased afterload: acute LV failure, APO, ALI, chronic pulmonary HTN, pulmonary infection, pulmonary embolus, chronic lung disease/hypoxia
Impaired contractility/relaxation: myocardial ischaemia/infarction, arrhythmias
other: sepsis, pericardial disease, congenital heart disease, valvulopathies (TCR, pulmonary stenosis), haematological disorders (eg. sickle cell syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

+What are the effects of chronic & acute increased afterload on the RV?

A

If chronically subjected (eg. chronic pulm HTN), RV progressively hypertrophies & increase contractility to maintain CO.

When compensation mechanisms exhausted, decompensation occurs (eg. RV volume overload–> incr RAP & CVP & systemic congestion–> end organ failure, RV pressure overload dilates the RV, contractility & output reduce, organ failure. May get arrhythmias which reduce coronary perfusion, CO & lead to end-organ failure).

Acute RV afterload increases (eg. acute pulmonary thromboembolism) cause increased RV EDV (dilation & contractility), yet acute compensations are often insufficient to maintain ejection from the thin-walled, less contractile RV & RV dysfunction can rapidly develop. This situation also occurs when an otherwise healthy RV is required to acutely generate mean pressures exceeding 40mmHg.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the 3 ways in which a RV chronically subjected to volume overload, which may become dilated & fail, can reduce LV preload?

A

Reduced RV contractility of the dilated chamber generates insufficient pressure to eject blood through pulmonary circulation
Dilated RV causes an elevated RVEDP which eventually exceeds LVEDP, causing compression/lessening of LV filling & ejection, also the bulging IV septum encroaches on the LV (ventricular interdependence), resulting in relative under filling of the LV
RV tricuspid annular dilatation & TCR reduces forward flow through pulmonary circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

+How is a dilated RV at more risk of ischaemia?

A

CorPP= ADP - RVEDP; (same for systole)- so incr RVEDP impedes coronary blood flow.
Dilated or distended RV is predisposed to hypotension-related ischaemia.
Dilated RV also increases R) atrial pressure which impairs systemic venous return, compounding these mechanisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

+What are examination findings of RV failure? and investigations?

A

non-specific signs of systemic venous congestion, including:
S3
TCR murmur
elevated JVP
hepatojugular reflux
pulsatile liver
peripheral oedema

and signs of low CO state:
hypotension
tachycardia
cool peripheries
oliguria

Biochemically:
increased lactate
deranged liver biochemistry (liver congestion +/- organ hypoperfusion from inadequate CO)
renal impairment
cardiac biomarkers: BNP, cardiac troponin T non-specific BUT elevations can correlate with reduced RV function after PE if also pulmonary HTN or after congenital cardiac surgery
Early studies: inflammatory biomarkers ST2 & sST2and GT-3 correlate with RV dysfunction in some disease-specific states incl pulm HTN & mechanical support

ECG: may be normal or may show RAD, R) BBB, RVH, S1Q3T3 triad of RV strain may occur

Echo: TAPSE <16mm, FAC <35%, higher MPI (on pulsed doppler >0.43, >0.54 on tissue doppler)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

+What proportion of pts with acute pulmonary embolism have the RV strain pattern on ecg of large S wave in lead I, Q wave & inverted T wave in lead III?

A

up to 10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

+What are strengths of TTE vs TOE for assessment of the RV anatomy & function?

A

anterior location of the R) heart makes TTE an ideal modality- qualitative assessment methods commonly used to assess RV function have only been validated for TTE.
TOE is limited by distance from the probe to relevant RV structures & poor doppler alignment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

+What are the most-used markers of RV function in TTE?

A

TAPSE (tricuspid annular plane systolic excursion)- measures movement of tricuspid annular plane longitudinally towards the apex of the RV in systole. Indicates RV free wall longitudinal contraction. Normal >16mm.
fractional area change (FAC)
Myocardial performance (Tei) index
TR (tricuspid regurgitant) jet velocity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

+What’s normal TAPSE?

A

> 16mm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

+What’s fractional area change (FAC) & normal value?

A

A measure of overall RV systolic function, taken in a 4-chamber view, % change in area between systole & diastole.
FAC <35% indicates RV systolic dysfunction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

+What’s the Tei index? in which situations is it not useful? normal values?

A

myocardial performance index, dimensionless, sum of isovolumetric contraction time & isovolumetric relaxation time divided by ejection time.
useful as it incorporates elements of systole & diastole.
Relies on a constant R-R interval so NOT useful in AF.
Normal values are <0.4 by pulsed doppler & <0.55 by tissue doppler.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

+How is tissue doppler imaging used to assess RV function?

A

measures longitudinal velocity of excursion of regions of the RV during systole- most commonly the tricuspid annulus & the basal free wall segment.

Systolic velocity reported as S’ with <10cm/sec raising suspicion for abnormal RV systolic function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

+What does measurement of the velocity of the TR jet allow?

A

if a TR jet is present, it permits estimation of RVSP. With the addition of RAP, this measure is equivalent to pulmonary artery systolic pressure in the absence of pulmonary stenosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

+Pre-operative TTE assessment HAS been shown to predict periop cardiac complications in non-cardiac surgery. Which parameters have predictive value?

A

lower TAPSE & increased Tei index.

FAC, sPAP & tissue doppler parameters didn’t have predictive value of periop cardiovascular complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

+What are some conditions that bedside TTE or intraop TOE could identify/exclude in the case of acute deterioration of RV function or unexplained haemodynamic instability?

A

acute PE
cardiac tamponade
RV MI
acute RV or LV dysfunction
acute valvulopathies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

+calculation of EF?

A

(SV/EDV) x 100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

+What’s the most accurate non-invasive technique to assess the RV? parameters?

A

cardiac MRI
mass, volume, EF, scar burden, myocardial strain, perfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

+Why does the RV have a higher EF than the LV? implications of this?

A

RV volumes are smaller
Means that a higher percentage of EDV needs to be ejected to maintain the equivalent SV & CO.

27
Q

+Normal RVEF?

A

47-75%

28
Q

+What information can be gained from a PA (Swan-Ganz) catheter? For which situations is it reserved? Is there evidence for it’s routine use?

A

Accurate assessment of RA & LA pressure, CO, direct monitoring of PA pressure, measure PVR, mixed venous O2 levels (SvO2), cardiac index.
Due to risks (PA rupture, arrhythmia), reserved for situations where having additional information (to assess RV failure when aetiology is unclear or there’s Rx resistance) outweighs risks involved.
No evidence.

29
Q

+What’s the scenario in which perioperative R) heart failure generally occurs? How should we therefore approach prevention of RHF?

A

“at risk” RV & an acute precipitating event impacting preload/afterload/contractility which precipitates decompensation

Identify pts early preop who are @ risk of RV failure, optimise RV furncjotn prior to OT, avoid conditions that may precipitate deterioration of RV function.

30
Q

+Which pt groups are at particular periop risk of developing RV failure?

A

Chronically elevated PVR (eg. severe COPD)
valvulopathies (eg. tricuspid or mitral valve disease)
congenital heart disease
ischemic heart disease

31
Q

+How to protect the RV?

A

RV doesn’t handle afterload well; support a failing RV with Rx that lower or prevent significant rises in PVR
A healthy RV handles increased preload well but a failing RV may need inotropic support the manage rapid increased preload
Ischaemic RV dysfunction should be managed by optimising myocardial O2 supply & demand

32
Q

+What are some reversible measures preoperatively which may help protect the at-risk RV?

A

-avoid hypoxaemia, hypercapnia, acidosis, hypothermia, drugs that increase PVR (N2O, ketamine (increases PVR in adults in large doses but generally OK), desflurane, VERY judicious use of metaraminol), ensure adequate anaesthetic depth & analgesia to limit SNS response, avoid high PEEP & lung hyperinflation. Consider pulmonary vasodilators (NO, prostacyclin), preferred vasopressor vasopressin

-Ensure adequate DO2: preserve RV perfusion with adequate MAP (RV perfuses in systole & diastole but if high RV pressures more dependent on diastole) & maintain preload to avoid vicious cycle of inadequate perfusion, RV ischaemia & poor CO; adequate Hb

-Preserve adequate preload (sepsis is a contributing factor), limit arrhythmias (impair RV filling), optimise fluid volume status

-maintain +ve inotropy

33
Q

+What are high-risk procedures for the R) heart?

A

-Those which may suddenly incr PVR & RV overload: those associated with venous air, CO2, fat or cement embolism (incl ortho & liver transplants)
-Any procedure requiring rapid large volume infusion
-activation of the systemic inflammatory response may –> large volume shifts & RV impairment if rapid fluid resus is needed
-pneumoperitoneum: effects on preload, afterload, contractility, hypercarbia, lung volumes, acidosis & pt positioning impacting ventilation & venous return.

34
Q

+Principles of preoperative optimisation & intraop management of pts with known elevations in PVR or with RV dysfunction?

A

risk stratify
optimise in liaison with multi-D team (cardiologist/resp physician)
continue all regular medications
ensure at tertiary centre, consider cardiac anaesthesia input +/- intraop TOE +/- postop ICU +/- availability fo mechanical support
appropriate informed consent

in addition to standard monitoring, art line (early identification & aggressive correction of systemic hypoT), consider CVC for prolonged procedures where large fluid shifts anticipated or in pts with severe disease (to measure CVP & deliver +ve inotropes- ALTHOUGH meta-analyses have found a limited relationship between CVP or delta-CVP in predicting haemodynamic response to a fluid challenge & CVP has a limited relationship with intravascular volume status),

availability of intraop TOE to Ax RV contractility, dilatation, IV septum & may identify precipitating factors such as PE & guide therapies aimed at optimising preload, afterload & contractility.

temp monitoring & active warming to reduce increases in PVR & limit shivering (which incr MRO2)

Conduct anaesthetic in a manner that preserves adequate preload (but doesn’t over-fill), avoids increases in RV afterload, maintains adequate RV contractility & cognisant of O2 supply meeting demand (eg. ensure adequate coronary perfusion). HR preferably faster (80-100bpm) to prevent excessive RV distension, LV distortion & worsening of TR but balance this against myocardial O2 demand. Limit arrhythmias (atrial tachys the most common, poorly tolerated). optimise K+ & Mg++ & other electrolytes to limit risk of new arrhythmias. DCCV= Rx of choice for haemodynamic instability. anti-arrhythmic of choice= amiodarone.

Induction: adequate pre-O2, gentle BMV (avoid hypercarbia & hypoxia but ensure not excessive Pit), ample blunting of SNS (analgesia, depth, complete NMB to limit cough/strain & incr PVR), vasopressors to aggressively manage post-induction hypoT

mech ventilation: avoid hypox/hypercarb/resp acidosis- PVR worsens if PaO2 <60mmHg due to HPV, hypercapnia increases PAP by 1mmHg per mmHg incr PaCO2. avoid atelectasis & high lung volumes- keep ventilation at FRC. Lung protective vent: TVs 6mL/kg, plateau pressures <30cmH2).

fluid: some pts with RV dysfunction become preload-dependent but excessive volume loading may precipitate RV over-distension & incr RV wall tension. use cautious IVT. Difficult to know if a pt fluid responsive; could try a passive SLR to 45 deg- if this produces a 2-5mmHg elevation in CVP & corrects MAP, fluid bolus indicated. Or, if CVP <12mmHg, could give 250-500mL IV crystalloid challenge. if RV dilated, diuresis may be indicated (ventricular offloading & reduction in RV filling pressures).

For GA, etomidate would be induction agent of choice (less effect on SVR, myocardial contractility & PVR) but n/a in Aust; propofol & thiopentone reduce RV contractility & SVR but don’t impact PVR so can usually be used safely with appropriate dose adjustment.

Ensure adequate NMB to optimise resp mechanics but must fully reverse TOFR>0.9 prior to extubation.

Judicious opioid; large doses blunt SNS tone, may precipitate systemic hypoT & reduce RV contractility + OIH may result in hypercarbia & incr PVR but need appropriate analgesia to mitigate SNS-mediated incr PVR (use opioid-sparing adjuncts & regional).

If neuraxial, carefully titrated epidural.

greatest risk of RV deterioration= postop. Generally ICU is appropriate in the immediate post-op period (depends on pt factors, surgery duration & complexity, anticipated ongoing fluid shifts, hypoV & vasopressor/inotropic requirements)
goals (as in OT):
avoid atelectasis (chest physio)
prevent hypoxia & hypercarbia
maintain temp management
optimise analgesia
THROMBOPROPHYLAXIS once haemostasis assured

35
Q

Is CVP a reliable indicator if intravascular volume status? Is CVP or delta-CVP reliable in predicting haemodynamic response to a fluid challenge?

A

No. Meta-analyses have found that CVP & delta-CVP are poor predictors of haemodynamic response to a fluid challenge

36
Q

Even though CVP may be shown to poorly correlate with intravascular volume status or predicting the haemodynamic response to a fluid challenge, how may CVP catheters be otherwise useful for pts with an “at risk” RV?

A

Monitor for new TCR (development of a dominant v wave & sharp y descent)

& measurement of SmvO2 as a marker of sufficiency of CO

Acute rise in CVP may suggest deteriorating RV function

37
Q

Why may there be a dominant V wave & sharp Y descent in TCR?

A

V wave represents RA filling during late ventricular systole; augmented with TCR- sometimes the V wave can become > a wave & the X descent may be obliterated (“ventricularisation”)
Y descent produced by TCV opening & rapid flow of blood to RV

38
Q

+Which is the anti-arrhythmic pharmacotherapy of choice for the “at risk” RV? why?

A

amiodarone
B-blockers & CCBs reduce inotropy & may further impair RV function

39
Q

+What are the principles of vasopressor use for the “at risk” RV/ in RV impaired states? choice of agent?

A

what to maintain RV myocardial perfusion

Want to increase SVR & either reduce or have no effect on PVR

NAdr improves coronary perfusion by increasing aortic root pressure BUT at doses of >0.5microg/kg/min it can incr PVR so generally it is limited to <0.2microg/kg/min

Vasopressin 1-4units/min can be used where NAdr has failed as it’s not associated with incr PVR; at low doses, it may be associated with DECREASED PVR

40
Q

+Which is the most commonly used inotrope in RV failure? at what doses? what effect does these doses have on CO, PVR & SVR?

A

dobutamine, a beta agonist
doses of 2-5microg/kg/min incr CO while simultaneously decreasing PVR
dobutamine may decrease SVR at the same, requiring co-administration of a vasopressor

41
Q

+At what doses may dopamine be used? what may limit it’s use?

A

low-dose dopamine at <5microg/kg/min may improve RV function in the setting of pulmonary vascular dysfunction but it’s use is limited by tachyarrhythmias

42
Q

+What’s milrinone & how may it be helpful in the “at risk” RV? dose? what’s an alternative route for use during a pulmonary hypertensive crisis?

A

A PDE-3 inhibitor
promotes myocardial contractility while reducing RV afterload (inodilator)
0.25-0.5microg/kg/min will reduce PA pressures & augment RV function but co-administration of a vasopressor is generally required

nebulised milrinone can be used in pulmonary hypertensive crisis- advantage of pulmonary selectivity, less systemic hypoT

43
Q

+How does levosimendan work? Benefits to diastolic function, myocardial contractility, myocardial O2 demand & PVR? duration of effects? On what ion is it’s action dependent? What limits it’s use in acute perioperative setting?

A

it’s a calcium sensitiser
acts via troponin C receptor to optimise myocardial response to calcium
it selectively inhibits PDEIII & acts on the ATP-sensitive sarcolemma K+ channels of smooth muscle

Overall improves diastolic function & myocardial contractility without increasing myocardial O2 demand & it induces ischaemic preconditioning. It reduces PVR & increases RV efficiency with actions over several days due to it’s active metabolite.

Levosimendan’s action is calcium-dependent so hypocalcaemia should be aggressively managed & corrected

Costly, need to administer via an IV infusion over 24hrs

44
Q

+What other inotropic agent may acutely improve CO by 10% in RV failure, without affecting HR? dose?

A

digoxin, 1mg

45
Q

+While pulmonary vasodilators reduce PVR & improve RV stroke volume, what’s the tradeoff? how mitigate?

A

risk systemic hypoT & may lead to hypoxaemia through V/Q mismatch.
Need to optimise RV perfusion prior to administration.

46
Q

In which patient groups is there the most evidence for use of pulmonary vasodilators?

A

Chronic pulm HTN, cardiac surgery (incl heart transplant), pts with mechanical cardiac support

47
Q

+What are some examples of prostanoids, how do they work?

A

IV epoprostenol, nebulised iloprost, subcut treprostinil
Increase pulmonary vascular prostacyclin I2 levels to promote pulm VD & reduce PVR

48
Q

+What are some examples of endothelin-1 antagonists? Mechanism?

A

Bosentan
Produce pulm VD by inhibiting endothelium-derived vasoconstrictor

49
Q

+What’s an example of a PO phosphodiesterase 5 inhibitor?

A

Sildenafil

50
Q

+What are some agents other than PDE5 inhibitors, endothelin 1 antagonists and prostanoids which may reduce PVR?

A

CCBs, adenosine, Mg++ & GTN

51
Q

+What are examples of mechanical support for the RV? When considered? Aim? Periop significance?

A

IABP (may improve RV function by augmenting coronary flow)
ECMO (limited to days or weeks)
Ventricular assistive devices (paracorporeal RVADs only approved for 1/52)
May be considered at specialist centres where RV failure occurs due to a reversible cause (eg. acute PE or RV ischaemia)
Aim to prevent multi-organ dysfunction by providing support until the RV recovers.
Pts with known RV failure should have consideration of elective surgeries being performed at a facility offering mechanical supports.

52
Q

+What’s acute R) heart syndrome?

A

rapidly progressing syndrome with systemic congestion resulting from impaired RV filling or reduced RV flow output

53
Q

+What’s the primary determinant of early mortality in acute PE?

A

new onset RV failure

54
Q

what clinically characterises a high-risk PE?

A

persistent arterial hypotension or shock caused by overt RV failure

55
Q

Normally, what mean PAP can the RV generate before it’s stroke volume declines?

A

40mmHg

56
Q

+In normal circumstances, what proportion of the pulmonary vasculature needs to be occluded with emoboli before RV failure ensues?

A

50-75%

57
Q

What’s the recommended strategy to achieve reperfusion in patients with high-risk PE? alternatives?

A

IV thrombolysis- this may be contraindicated perioperatively due to bleeding risk
alternatives= surgical pulmonary thrombectomy (if an absolute contraindication to thrombolysis) or IR approaches (if relative contraindication)

58
Q

+What type of MI is caused by proximal RCA occlusion? what proportion of pts with this pathology develop RV impairment?

A

acute inferior myocardial ischaemia- RV is most at risk
30-50% of pts with pros RCA occlusion develop RV impairment

59
Q

What factors help protect the RV from failure with threatened ischaemia?

A

relatively low O2 demand, superior O2 extraction reserve, frequent dual vascular supply & increased collateralisation in pts with chronic ischaemic ventricles

60
Q

+What’s the preferable Rx for pts with prox RCA occlusion? to what complications are pts vulnerable while awaiting reperfusion? which drugs must be avoided & why?

A

primary PCI for early myocardial reperfusion.
VT, bradycardia requiring atropine, high-grade AV block requiring pacing.
nitrates & diuretics may compromise RV preload & should be avoided; inotropic support may be required.

61
Q

+Describe the lung-protective ventilation strategy for the vulnerable RV?

A

TV 6mL/kg, plateau pressures <30cmH2O, avoid excess PEEP (max 10cmH2O)

62
Q

+Below which PaO2 does PVR worsen due to HPV>

A

60mmHg

63
Q

+By how much does PAP increase with each 1mmHg incr PaCO2?

A

1mmHg

64
Q

+What’s the HR target for the “at risk” RV?

A

faster- 80-100bpm- to avoid RV over-distension, limit LV distortion & avoid worsening of TR, but cognisant of myocardial O2 demand.